Global and United States Pneumonia Therapeutics Market Report & Forecast 2024-2031

Report ID: 1860433 | Published Date: Oct 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pneumonia Therapeutics Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Pneumonia Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Pneumonia Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Pneumonia Therapeutics Market Size for the Year 2017-2028
    1.3 Pneumonia Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Pneumonia Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Pneumonia Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Pneumonia Therapeutics Market Dynamics
        1.4.1 Pneumonia Therapeutics Industry Trends
        1.4.2 Pneumonia Therapeutics Market Drivers
        1.4.3 Pneumonia Therapeutics Market Challenges
        1.4.4 Pneumonia Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Pneumonia Therapeutics by Type
    2.1 Pneumonia Therapeutics Market Segment by Type
        2.1.1 Vaccines
        2.1.2 Anti-Infectives
        2.1.3 Oxygen Therapy
    2.2 Global Pneumonia Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Pneumonia Therapeutics Market Size by Type (2017-2028)
    2.4 United States Pneumonia Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Pneumonia Therapeutics Market Size by Type (2017-2028)
3 Pneumonia Therapeutics by Application
    3.1 Pneumonia Therapeutics Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Medical Center
        3.1.4 Other
    3.2 Global Pneumonia Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Pneumonia Therapeutics Market Size by Application (2017-2028)
    3.4 United States Pneumonia Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Pneumonia Therapeutics Market Size by Application (2017-2028)
4 Global Pneumonia Therapeutics Competitor Landscape by Company
    4.1 Global Pneumonia Therapeutics Market Size by Company
        4.1.1 Top Global Pneumonia Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Pneumonia Therapeutics Revenue by Player (2017-2022)
    4.2 Global Pneumonia Therapeutics Concentration Ratio (CR)
        4.2.1 Pneumonia Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Pneumonia Therapeutics in 2021
        4.2.3 Global Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Pneumonia Therapeutics Headquarters, Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Pneumonia Therapeutics Headquarters and Area Served
        4.3.2 Global Pneumonia Therapeutics Companies Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Pneumonia Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Pneumonia Therapeutics Market Size by Company
        4.5.1 Top Pneumonia Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Pneumonia Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Pneumonia Therapeutics Market Size by Region
    5.1 Global Pneumonia Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Pneumonia Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Pneumonia Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Pneumonia Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Pneumonia Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Pneumonia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Pneumonia Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Pneumonia Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Pneumonia Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Pneumonia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Pneumonia Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Pneumonia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Pneumonia Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Pneumonia Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Company Details
        7.1.2 GlaxoSmithKline Business Overview
        7.1.3 GlaxoSmithKline Pneumonia Therapeutics Introduction
        7.1.4 GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.1.5 GlaxoSmithKline Recent Development
    7.2 Merck Sharp & Dohme
        7.2.1 Merck Sharp & Dohme Company Details
        7.2.2 Merck Sharp & Dohme Business Overview
        7.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Introduction
        7.2.4 Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.2.5 Merck Sharp & Dohme Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Pneumonia Therapeutics Introduction
        7.3.4 Novartis Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Details
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Pneumonia Therapeutics Introduction
        7.4.4 Pfizer Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.4.5 Pfizer Recent Development
    7.5 AstraZeneca
        7.5.1 AstraZeneca Company Details
        7.5.2 AstraZeneca Business Overview
        7.5.3 AstraZeneca Pneumonia Therapeutics Introduction
        7.5.4 AstraZeneca Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.5.5 AstraZeneca Recent Development
    7.6 Bayer
        7.6.1 Bayer Company Details
        7.6.2 Bayer Business Overview
        7.6.3 Bayer Pneumonia Therapeutics Introduction
        7.6.4 Bayer Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.6.5 Bayer Recent Development
    7.7 Biotest
        7.7.1 Biotest Company Details
        7.7.2 Biotest Business Overview
        7.7.3 Biotest Pneumonia Therapeutics Introduction
        7.7.4 Biotest Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.7.5 Biotest Recent Development
    7.8 Tetraphase Pharmaceuticals
        7.8.1 Tetraphase Pharmaceuticals Company Details
        7.8.2 Tetraphase Pharmaceuticals Business Overview
        7.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Introduction
        7.8.4 Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2017-2022)
        7.8.5 Tetraphase Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Pneumonia Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Pneumonia Therapeutics Market Trends
    Table 3. Pneumonia Therapeutics Market Drivers
    Table 4. Pneumonia Therapeutics Market Challenges
    Table 5. Pneumonia Therapeutics Market Restraints
    Table 6. Global Pneumonia Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pneumonia Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pneumonia Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pneumonia Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pneumonia Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pneumonia Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Pneumonia Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Pneumonia Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pneumonia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Therapeutics as of 2021)
    Table 15. Top Players of Pneumonia Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Pneumonia Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Pneumonia Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Pneumonia Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Pneumonia Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Pneumonia Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Pneumonia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Pneumonia Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Pneumonia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Pneumonia Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Pneumonia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Pneumonia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Pneumonia Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. GlaxoSmithKline Company Details
    Table 31. GlaxoSmithKline Business Overview
    Table 32. GlaxoSmithKline Pneumonia Therapeutics Product
    Table 33. GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. GlaxoSmithKline Recent Development
    Table 35. Merck Sharp & Dohme Company Details
    Table 36. Merck Sharp & Dohme Business Overview
    Table 37. Merck Sharp & Dohme Pneumonia Therapeutics Product
    Table 38. Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Merck Sharp & Dohme Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Pneumonia Therapeutics Product
    Table 43. Novartis Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Pfizer Company Details
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Pneumonia Therapeutics Product
    Table 48. Pfizer Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. AstraZeneca Company Details
    Table 51. AstraZeneca Business Overview
    Table 52. AstraZeneca Pneumonia Therapeutics Product
    Table 53. AstraZeneca Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. AstraZeneca Recent Development
    Table 55. Bayer Company Details
    Table 56. Bayer Business Overview
    Table 57. Bayer Pneumonia Therapeutics Product
    Table 58. Bayer Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Bayer Recent Development
    Table 60. Biotest Company Details
    Table 61. Biotest Business Overview
    Table 62. Biotest Pneumonia Therapeutics Product
    Table 63. Biotest Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Biotest Recent Development
    Table 65. Tetraphase Pharmaceuticals Company Details
    Table 66. Tetraphase Pharmaceuticals Business Overview
    Table 67. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product
    Table 68. Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Tetraphase Pharmaceuticals Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pneumonia Therapeutics Product Picture
    Figure 2. Global Pneumonia Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pneumonia Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Pneumonia Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Pneumonia Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Pneumonia Therapeutics Market Share in Global 2017-2028
    Figure 7. Pneumonia Therapeutics Report Years Considered
    Figure 8. Product Picture of Vaccines
    Figure 9. Product Picture of Anti-Infectives
    Figure 10. Product Picture of Oxygen Therapy
    Figure 11. Global Pneumonia Therapeutics Market Share by Type in 2022 & 2028
    Figure 12. Global Pneumonia Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Pneumonia Therapeutics Market Share by Type (2017-2028)
    Figure 14. United States Pneumonia Therapeutics Market Share by Type in 2022 & 2028
    Figure 15. United States Pneumonia Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Pneumonia Therapeutics Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital
    Figure 18. Product Picture of Clinic
    Figure 19. Product Picture of Medical Center
    Figure 20. Product Picture of Other
    Figure 21. Global Pneumonia Therapeutics Market Share by Application in 2022 & 2028
    Figure 22. Global Pneumonia Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Pneumonia Therapeutics Market Share by Application (2017-2028)
    Figure 24. United States Pneumonia Therapeutics Market Share by Application in 2022 & 2028
    Figure 25. United States Pneumonia Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Pneumonia Therapeutics Market Share by Application (2017-2028)
    Figure 27. North America Pneumonia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Pneumonia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Pneumonia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Pneumonia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Pneumonia Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Pneumonia Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. GlaxoSmithKline Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 56. Merck Sharp & Dohme Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 59. AstraZeneca Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 61. Biotest Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 62. Tetraphase Pharmaceuticals Revenue Growth Rate in Pneumonia Therapeutics Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Merck Sharp & Dohme
Novartis
Pfizer
AstraZeneca
Bayer
Biotest
Tetraphase Pharmaceuticals
Frequently Asked Questions
Pneumonia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pneumonia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pneumonia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports